BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18693280)

  • 1. Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.
    Vreeswijk MP; Kraan JN; van der Klift HM; Vink GR; Cornelisse CJ; Wijnen JT; Bakker E; van Asperen CJ; Devilee P
    Hum Mutat; 2009 Jan; 30(1):107-14. PubMed ID: 18693280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from "Uncertain Significance" to "Pathogenic" based on minigene assays and clinical evidence.
    Ning Y; Zhang Y; Tian T; Chen Y; Wang J; Lei K; Cui Z
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):62. PubMed ID: 38300310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.
    de la Hoya M; Soukarieh O; López-Perolio I; Vega A; Walker LC; van Ierland Y; Baralle D; Santamariña M; Lattimore V; Wijnen J; Whiley P; Blanco A; Raponi M; Hauke J; Wappenschmidt B; Becker A; Hansen TV; Behar R; Investigators K; Niederacher D; Arnold N; Dworniczak B; Steinemann D; Faust U; Rubinstein W; Hulick PJ; Houdayer C; Caputo SM; Castera L; Pesaran T; Chao E; Brewer C; Southey MC; van Asperen CJ; Singer CF; Sullivan J; Poplawski N; Mai P; Peto J; Johnson N; Burwinkel B; Surowy H; Bojesen SE; Flyger H; Lindblom A; Margolin S; Chang-Claude J; Rudolph A; Radice P; Galastri L; Olson JE; Hallberg E; Giles GG; Milne RL; Andrulis IL; Glendon G; Hall P; Czene K; Blows F; Shah M; Wang Q; Dennis J; Michailidou K; McGuffog L; Bolla MK; Antoniou AC; Easton DF; Couch FJ; Tavtigian S; Vreeswijk MP; Parsons M; Meeks HD; Martins A; Goldgar DE; Spurdle AB
    Hum Mol Genet; 2016 Jun; 25(11):2256-2268. PubMed ID: 27008870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
    Parsons MT; Tudini E; Li H; Hahnen E; Wappenschmidt B; Feliubadaló L; Aalfs CM; Agata S; Aittomäki K; Alducci E; Alonso-Cerezo MC; Arnold N; Auber B; Austin R; Azzollini J; Balmaña J; Barbieri E; Bartram CR; Blanco A; Blümcke B; Bonache S; Bonanni B; Borg Å; Bortesi B; Brunet J; Bruzzone C; Bucksch K; Cagnoli G; Caldés T; Caliebe A; Caligo MA; Calvello M; Capone GL; Caputo SM; Carnevali I; Carrasco E; Caux-Moncoutier V; Cavalli P; Cini G; Clarke EM; Concolino P; Cops EJ; Cortesi L; Couch FJ; Darder E; de la Hoya M; Dean M; Debatin I; Del Valle J; Delnatte C; Derive N; Diez O; Ditsch N; Domchek SM; Dutrannoy V; Eccles DM; Ehrencrona H; Enders U; Evans DG; Farra C; Faust U; Felbor U; Feroce I; Fine M; Foulkes WD; Galvao HCR; Gambino G; Gehrig A; Gensini F; Gerdes AM; Germani A; Giesecke J; Gismondi V; Gómez C; Gómez Garcia EB; González S; Grau E; Grill S; Gross E; Guerrieri-Gonzaga A; Guillaud-Bataille M; Gutiérrez-Enríquez S; Haaf T; Hackmann K; Hansen TVO; Harris M; Hauke J; Heinrich T; Hellebrand H; Herold KN; Honisch E; Horvath J; Houdayer C; Hübbel V; Iglesias S; Izquierdo A; James PA; Janssen LAM; Jeschke U; Kaulfuß S; Keupp K; Kiechle M; Kölbl A; Krieger S; Kruse TA; Kvist A; Lalloo F; Larsen M; Lattimore VL; Lautrup C; Ledig S; Leinert E; Lewis AL; Lim J; Loeffler M; López-Fernández A; Lucci-Cordisco E; Maass N; Manoukian S; Marabelli M; Matricardi L; Meindl A; Michelli RD; Moghadasi S; Moles-Fernández A; Montagna M; Montalban G; Monteiro AN; Montes E; Mori L; Moserle L; Müller CR; Mundhenke C; Naldi N; Nathanson KL; Navarro M; Nevanlinna H; Nichols CB; Niederacher D; Nielsen HR; Ong KR; Pachter N; Palmero EI; Papi L; Pedersen IS; Peissel B; Perez-Segura P; Pfeifer K; Pineda M; Pohl-Rescigno E; Poplawski NK; Porfirio B; Quante AS; Ramser J; Reis RM; Revillion F; Rhiem K; Riboli B; Ritter J; Rivera D; Rofes P; Rump A; Salinas M; Sánchez de Abajo AM; Schmidt G; Schoenwiese U; Seggewiß J; Solanes A; Steinemann D; Stiller M; Stoppa-Lyonnet D; Sullivan KJ; Susman R; Sutter C; Tavtigian SV; Teo SH; Teulé A; Thomassen M; Tibiletti MG; Tischkowitz M; Tognazzo S; Toland AE; Tornero E; Törngren T; Torres-Esquius S; Toss A; Trainer AH; Tucker KM; van Asperen CJ; van Mackelenbergh MT; Varesco L; Vargas-Parra G; Varon R; Vega A; Velasco Á; Vesper AS; Viel A; Vreeswijk MPG; Wagner SA; Waha A; Walker LC; Walters RJ; Wang-Gohrke S; Weber BHF; Weichert W; Wieland K; Wiesmüller L; Witzel I; Wöckel A; Woodward ER; Zachariae S; Zampiga V; Zeder-Göß C; ; Lázaro C; De Nicolo A; Radice P; Engel C; Schmutzler RK; Goldgar DE; Spurdle AB
    Hum Mutat; 2019 Sep; 40(9):1557-1578. PubMed ID: 31131967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA2 T2722R is a deleterious allele that causes exon skipping.
    Fackenthal JD; Cartegni L; Krainer AR; Olopade OI
    Am J Hum Genet; 2002 Sep; 71(3):625-31. PubMed ID: 12145750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
    Thomassen M; Mesman RLS; Hansen TVO; Menendez M; Rossing M; Esteban-Sánchez A; Tudini E; Törngren T; Parsons MT; Pedersen IS; Teo SH; Kruse TA; Møller P; Borg Å; Jensen UB; Christensen LL; Singer CF; Muhr D; Santamarina M; Brandao R; Andresen BS; Feng BJ; Canson D; Richardson ME; Karam R; Pesaran T; LaDuca H; Conner BR; Abualkheir N; Hoang L; Calléja FMGR; Andrews L; James PA; Bunyan D; Hamblett A; Radice P; Goldgar DE; Walker LC; Engel C; Claes KBM; Macháčková E; Baralle D; Viel A; Wappenschmidt B; Lazaro C; Vega A; ; Vreeswijk MPG; de la Hoya M; Spurdle AB
    Hum Mutat; 2022 Dec; 43(12):1921-1944. PubMed ID: 35979650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing.
    Kawakami R; Hiraide T; Watanabe K; Miyamoto S; Hira K; Komatsu K; Ishigaki H; Sakaguchi K; Maekawa M; Yamashita K; Fukuda T; Miyairi I; Ogata T; Saitsu H
    J Hum Genet; 2024 Feb; 69(2):91-99. PubMed ID: 38102195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
    Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
    Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing.
    Leman R; Parfait B; Vidaud D; Girodon E; Pacot L; Le Gac G; Ka C; Ferec C; Fichou Y; Quesnelle C; Aucouturier C; Muller E; Vaur D; Castera L; Boulouard F; Ricou A; Tubeuf H; Soukarieh O; Gaildrat P; Riant F; Guillaud-Bataille M; Caputo SM; Caux-Moncoutier V; Boutry-Kryza N; Bonnet-Dorion F; Schultz I; Rossing M; Quenez O; Goldenberg L; Harter V; Parsons MT; Spurdle AB; Frébourg T; Martins A; Houdayer C; Krieger S
    Hum Mutat; 2022 Dec; 43(12):2308-2323. PubMed ID: 36273432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
    Colombo M; Lòpez-Perolio I; Meeks HD; Caleca L; Parsons MT; Li H; De Vecchi G; Tudini E; Foglia C; Mondini P; Manoukian S; Behar R; Garcia EBG; Meindl A; Montagna M; Niederacher D; Schmidt AY; Varesco L; Wappenschmidt B; Bolla MK; Dennis J; Michailidou K; Wang Q; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadel A; Benitez J; Boeckx B; Bogdanova NV; Bojesen SE; Bonanni B; Brauch H; Brenner H; Burwinkel B; Chang-Claude J; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Eriksson M; Fasching PA; Figueroa J; Fletcher O; Flyger H; Gabrielson M; García-Closas M; Giles GG; González-Neira A; Guénel P; Haiman CA; Hall P; Hamann U; Hartman M; Hauke J; Hollestelle A; Hopper JL; Jakubowska A; Jung A; Kosma VM; Lambrechts D; Le Marchand L; Lindblom A; Lubinski J; Mannermaa A; Margolin S; Miao H; Milne RL; Neuhausen SL; Nevanlinna H; Olson JE; Peterlongo P; Peto J; Pylkäs K; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneeweiss A; Schoemaker MJ; See MH; Southey MC; Swerdlow A; Teo SH; Toland AE; Tomlinson I; Truong T; van Asperen CJ; van den Ouweland AMW; van der Kolk LE; Winqvist R; Yannoukakos D; Zheng W; ; Dunning AM; Easton DF; Henderson A; Hogervorst FBL; Izatt L; Offitt K; Side LE; van Rensburg EJ; Embrace S; Hebon S; McGuffog L; Antoniou AC; Chenevix-Trench G; Spurdle AB; Goldgar DE; Hoya M; Radice P
    Hum Mutat; 2018 May; 39(5):729-741. PubMed ID: 29460995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity.
    Hirschi OR; Felker SA; Rednam SP; Vallance KL; Parsons DW; Roy A; Cooper GM; Plon SE
    medRxiv; 2023 Nov; ():. PubMed ID: 37961416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites.
    Zhang P; Chaldebas M; Ogishi M; Al Qureshah F; Ponsin K; Feng Y; Rinchai D; Milisavljevic B; Han JE; Moncada-Vélez M; Keles S; Schröder B; Stenson PD; Cooper DN; Cobat A; Boisson B; Zhang Q; Boisson-Dupuis S; Abel L; Casanova JL
    Proc Natl Acad Sci U S A; 2023 Nov; 120(46):e2314225120. PubMed ID: 37931111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational prediction of human deep intronic variation.
    Barbosa P; Savisaar R; Carmo-Fonseca M; Fonseca A
    Gigascience; 2022 Dec; 12():. PubMed ID: 37878682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking splice variant prediction algorithms using massively parallel splicing assays.
    Smith C; Kitzman JO
    Genome Biol; 2023 Dec; 24(1):294. PubMed ID: 38129864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDIVAS: Pathogenicity predictor for Deep-Intronic Variants causing Aberrant Splicing.
    Kurosawa R; Iida K; Ajiro M; Awaya T; Yamada M; Kosaki K; Hagiwara M
    BMC Genomics; 2023 Oct; 24(1):601. PubMed ID: 37817060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SpliceVault predicts the precise nature of variant-associated mis-splicing.
    Dawes R; Bournazos AM; Bryen SJ; Bommireddipalli S; Marchant RG; Joshi H; Cooper ST
    Nat Genet; 2023 Feb; 55(2):324-332. PubMed ID: 36747048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation.
    Truty R; Ouyang K; Rojahn S; Garcia S; Colavin A; Hamlington B; Freivogel M; Nussbaum RL; Nykamp K; Aradhya S
    Am J Hum Genet; 2021 Apr; 108(4):696-708. PubMed ID: 33743207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A deep intronic DLG4 variant resulting in DLG4-related synaptopathy.
    Levy AM; Ganapathi M; Chung WK; Tümer Z
    Clin Genet; 2024 Jan; 105(1):77-80. PubMed ID: 37525972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound heterozygous splicing variants expand the genotypic spectrum of EMC1-related disorders.
    Bryen SJ; Zhang K; Dziaduch G; Bommireddipalli S; Naseri T; Reupena MS; Viali S; Minster RL; Waddell LB; Charlton A; O'Grady GL; Evesson FJ; Cooper ST
    Clin Genet; 2023 May; 103(5):553-559. PubMed ID: 36799557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting RNA splicing from DNA sequence using Pangolin.
    Zeng T; Li YI
    Genome Biol; 2022 Apr; 23(1):103. PubMed ID: 35449021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.